Intrathecal α-conotoxins Vc1.1, AuIB and MII acting on distinct nicotinic receptor subtypes reverse signs of neuropathic pain

Overview of attention for article published in Neuropharmacology, January 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 52 Dimensions

Readers on

mendeley: 37 Mendeley
citeulike: 1 CiteULike

Summary Patents Dimensions citations

So far, Dimensions has found 52 publications that cite this research output.

52

The most recent citing publications are shown below. View all 52 publications that cite this research output on Dimensions.

Rational Design of Potent α-Conotoxin PeIA Analogues with Non-Natural Amino Acids for the Inhibition of Human α9α10 Nicotinic Acetylcholine Receptors

Article in Marine Drugs (February 2024)

Exploring Cholinergic Compounds for Peripheral Neuropathic Pain Management: A Comprehensive Scoping Review of Rodent Model Studies

Article in Pharmaceuticals (September 2023)

α7- and α9-Containing Nicotinic Acetylcholine Receptors in the Functioning of Immune System and in Pain

Article in International Journal of Molecular Sciences (March 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.